Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for Chronic Hepatitis B Virus Infection, in Healthy Adults [Phase 1]

View source ↗

Summary

A phase 1 clinical trial is evaluating the safety and immunogenicity of an investigational hepatitis B vaccine in healthy adults. The study, sponsored by AstriV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Investigational hepatitis B vaccine

Snippet

Sponsor: AstriVax Therapeutics | Conditions: Chronic Hepatitis b | Phase 1 | Status: ACTIVE_NOT_RECRUITING